VVP
IART icon

Venture Visionary Partners’s Integra LifeSciences IART Stock Holding History

Venture Visionary Partners’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-36
Closed -$1.95K – 954
2022
Q2 		$1.95K Buy
+36
New +$2.16K ﹤0.01% 1539

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Venture Visionary Partners's IART Position: Q3 2022 in Review

Venture Visionary Partners sold out of Integra LifeSciences (IART) in Q3 2022, closing a stake of 36 shares — an estimated $1.95K sold.

Venture Visionary Partners first reported a position in IART in Q2 2022 and held it in 1 quarter. The position peaked at $1.95K in Q2 2022. 282 funds tracked by Wall St. Rank hold IART as of Q3 2022.

  • Venture Visionary Partners reported no remaining Integra LifeSciences position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 36 Integra LifeSciences shares in Q3 2022, an estimated $1.95K.
  • Venture Visionary Partners first reported a position in Integra LifeSciences in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's Integra LifeSciences position peaked at $1.95K in Q2 2022.
  • 282 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.